Literature DB >> 15037717

Proton MR spectroscopy in succinic semialdehyde dehydrogenase deficiency.

T Ethofer1, U Seeger, U Klose, M Erb, B Kardatzki, E Kraft, G B Landwehrmeyer, W Grodd, A Storch.   

Abstract

Succinic semialdehyde dehydrogenase (SSADH) deficiency is a rare hereditary disorder of the CNS catabolism of gamma-aminobutyric acid (GABA), leading to accumulation of the metabolite 4-hydroxybutyrate (GHB). Here the authors report on 1.5 and 3.0 T proton MR spectroscopy in a patient with SSADH deficiency. A characteristic pattern with clearly elevated GABA levels and traces of GHB was found in both the white and the gray matter of the brain. In vivo spectroscopy may be useful for diagnosis and monitoring SSADH deficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037717     DOI: 10.1212/01.wnl.0000115385.45515.df

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.

Authors:  Kyung-Jin Kim; Phillip L Pearl; Kimmo Jensen; O Carter Snead; Patrizia Malaspina; Cornelis Jakobs; K Michael Gibson
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

2.  Efficacy of vigabatrin intervention in a mild phenotypic expression of succinic semialdehyde dehydrogenase deficiency.

Authors:  M Casarano; M G Alessandrì; G S Salomons; E Moretti; C Jakobs; K M Gibson; G Cioni; R Battini
Journal:  JIMD Rep       Date:  2011-09-06

3.  Cerebellar atrophy in human and murine succinic semialdehyde dehydrogenase deficiency.

Authors:  Maria T Acosta; Jeeva Munasinghe; Phillip L Pearl; Maneesh Gupta; Andrey Finegersh; K Michael Gibson; William H Theodore
Journal:  J Child Neurol       Date:  2010-05-05       Impact factor: 1.987

4.  Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency.

Authors:  P L Pearl; K M Gibson; Z Quezado; I Dustin; J Taylor; S Trzcinski; J Schreiber; K Forester; P Reeves-Tyer; C Liew; S Shamim; P Herscovitch; R Carson; J Butman; C Jakobs; W Theodore
Journal:  Neurology       Date:  2009-08-11       Impact factor: 9.910

Review 5.  Succinic semialdehyde dehydrogenase deficiency: lessons from mice and men.

Authors:  P L Pearl; K M Gibson; M A Cortez; Y Wu; O Carter Snead; I Knerr; K Forester; J M Pettiford; C Jakobs; W H Theodore
Journal:  J Inherit Metab Dis       Date:  2009-01-28       Impact factor: 4.982

Review 6.  Seizures and metabolic disease.

Authors:  Phillip L Pearl; Heather D Bennett; Zarir Khademian
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

Review 7.  Neuroimaging findings in children with paediatric neurotransmitter diseases.

Authors:  Wang-Tso Lee; Wen-Chin Weng; Shinn-Forng Peng; Kai-Yuan Tzen
Journal:  J Inherit Metab Dis       Date:  2009-05-20       Impact factor: 4.982

8.  Polysomnographic abnormalities in succinic semialdehyde dehydrogenase (SSADH) deficiency.

Authors:  Phillip L Pearl; Sadat Shamim; William H Theodore; K Michael Gibson; Katherine Forester; Susan E Combs; Daniel Lewin; Irene Dustin; Patricia Reeves-Tyer; Cornelis Jakobs; Susumu Sato
Journal:  Sleep       Date:  2009-12       Impact factor: 5.849

9.  Inherited disorders of GABA metabolism.

Authors:  Phillip L Pearl; Thomas R Hartka; Jessica L Cabalza; Jacob Taylor; Michael K Gibson
Journal:  Future Neurol       Date:  2006-09

10.  A new case of GABA transaminase deficiency facilitated by proton MR spectroscopy.

Authors:  Megumi Tsuji; Noriko Aida; Takayuki Obata; Moyoko Tomiyasu; Noritaka Furuya; Kenji Kurosawa; Abdellatif Errami; K Michael Gibson; Gajja S Salomons; Cornelis Jakobs; Hitoshi Osaka
Journal:  J Inherit Metab Dis       Date:  2010-01-06       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.